Angiodroid

29/12/2025

As we close 2025, we look back at a year marked by meaningful milestones and shared responsibility 🎇

From scientific evidence to institutional dialogue,
from hospitals to national platforms,
this year showed how innovation can responsibly enter real clinical and public spaces.

𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝘁𝗼 𝗮𝗹𝗹 𝗰𝗹𝗶𝗻𝗶𝗰𝗶𝗮𝗻𝘀, 𝗶𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗶𝗼𝗻𝘀, 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝗮𝗻𝗱 𝗮𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻𝘀 𝘄𝗵𝗼 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗲𝗱 𝘁𝗼 𝘁𝗵𝗶𝘀 𝗷𝗼𝘂𝗿𝗻𝗲𝘆 𝗮𝗻𝗱 𝗵𝗲𝗹𝗽𝗲𝗱 𝘁𝘂𝗿𝗻 𝘃𝗶𝘀𝗶𝗼𝗻 𝗶𝗻𝘁𝗼 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗶𝗺𝗽𝗮𝗰𝘁.

We step into 2026 with clarity and commitment, continuing to work toward safer, more sustainable imaging — 𝗮𝗹𝘄𝗮𝘆𝘀 𝘄𝗶𝘁𝗵 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗰𝗲𝗻𝘁𝗲𝗿.

𝗦𝗮𝘃𝗲 𝘁𝗵𝗲 𝗞𝗶𝗱𝗻𝗲𝘆𝘀. 𝗦𝗵𝗮𝗽𝗲 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲. 🤍

16/12/2025

🔵 ANGIOWORKSHOP 2026 | JAN–MAR
From evidence to practice.
From innovation to standard of care.

The first hashtag of 2026 are now open.
🔹 Live cases & procedural sessions
🔹 CO₂-first clinical approach
🔹 Renal-protective strategies across procedures
🔹 Hands-on training & real-world insights

➡️ Register here: https://lnkd.in/dCFWhKi7

For additional information, feel free to contact us at marketing@angiodroid.com

Leading CO₂ education. Shaping clinical standards.

11/12/2025

🎬 There are stories that don’t begin with a business plan, but with an intuition.
And sometimes, that intuition rewrites an entire field.

This is Sebastiano Zannoli’s journey — the Founder of Angiodroid.
A story that starts in an unexpected moment: a conversation with his father, a physics professor, who planted a simple yet powerful idea.
From there, everything changed.

Sebastiano immediately sensed a gap that no one had dared to fill:
👉 an automatic system for CO₂ angiography — something that didn’t exist, but desperately needed to.

He believed in it so deeply that he made a decision few would have the courage to take:
create a company from scratch, alone, against the odds and against advice.
Because sometimes you don’t follow a trend — you follow a truth. And his truth was clear: “The need was real. The technology would be truly useful.”

His courage. His clarity. His instinct to serve patients first.
This is the foundation on which Angiodroid was built — and the reason we continue to move forward, every single day.

28/11/2025

💡Dalla sala operatoria ai riflettori di Rai 2.📺
[English below]

Lo scorso Mercoledì, 26 Novembre, il Prof. Mauro Gargiulo ha spiegato durante la rubrica Rai 2 33 perché la ​ è ormai diventata lo , nella sua pratica clinica di tutti i giorni, per la in angiografia. Non perdete la clip dell'intervista e tutti i punti salienti nel nostro articolo completo: 👇🏻
https://www.angiodroid.com/it/newsroom/rivoluzione-in-angiografia-le-parole-del-prof.-mauro-gargiulo-sulla-co2-a-medicina-33



-----

💡From the operating room to the spotlight of Rai 2. 📺

Last Wednesday, November 26th, Prof. Mauro Gargiulo explained on TV why ​ is becoming for him the for in . Don't miss the clip or the key takeaways—read the full story here: https://www.angiodroid.com/newsroom/revolution-in-angiography-prof.-gargiulo-explains-co2-on-medicina-33

14/11/2025

🌍💙 World Diabetes Day: Focus on ! 🛡️

is a primary cause of Chronic Kidney Disease ( ). Choosing the tools is . ⚠️

For diabetic patients with CKD undergoing procedures, Carbon Dioxide ( ​) is the :
☝It avoids the of iodinated contrast.
✌It protects highly kidneys.
👌Backed by strong , CO2​ is the .

for renal health. for patient safety. 🔬✨

Read more about it here:
➡️ https://lnkd.in/d4HBb6dq
➡️ https://lnkd.in/dZziv-Nv
➡️ https://lnkd.in/dpkaxd2h
➡️ https://lnkd.in/dvtUzKpY
➡️ https://lnkd.in/dvM9U4zs

12/11/2025

⚜️ Angiodroid Workshop in Madinah, Saudi Arabia ⚜️

An inspiring took place in Madinah, gathering radiographers, doctors, and students eager to explore the potential of .

The event, organized in collaboration with our partner Tamer Group, featured Mr. Raed Saad Alahmadi, Senior IR Technician and Head of Technologists in IR at King Fahad Hospital – Madinah Health Cluster, who presented two clinical case studies carried out at his hospital — one and one — highlighting the safety and effectiveness of technology in daily practice.

The session also featured the valuable contribution of Wessam Nabil, our Clinical Specialist MENA, who guided participants through the clinical principles and practical applications of CO₂ angiography, fostering an engaging and interactive learning experience.

A special thanks to for their continued commitment to spreading CO₂ knowledge and supporting professionals in adopting across 🙏

05/11/2025

🌐 At , CO₂ didn’t just take part — it took the stage.

Three live sessions, three operating rooms, three different teams.
One clear message: is no longer an alternative. It’s the future of vascular imaging.

🎯 Prof. Mauro Gargiulo – Bologna, Italy
Use of CO₂ in the Endovascular Treatment of an Abdominal Aortic Aneurysm
🎯 Prof. Matteo Tozzi – Varese, Italy
Automated CO₂ Angiography in the Maintenance of Vascular Access
🎯 Prof. Tamer Fekry – Cairo, Egypt
EVAR with CO₂ – Clinical Experience from Kobry El Kobba Medical Complex

From Europe to the Middle East, the same conclusion emerged:
CO₂ works. CO₂ protects. CO₂ belongs in the standard of care.

And this is just the beginning.

30/10/2025

30/10/2025

29/10/2025

Nurturing Growth, Ensuring Stability.

From optimizing processes to supporting people — ensuring compliance, managing resources, and building talent — they keep the structure solid, reliably, every single day.

This is a glimpse into the world of our HR & Finance team. The ones who balance our growth and sustain our mission 📈🤝

22/10/2025

🎙 Interview with Prof. med. Sabine Steiner – Universitätsklinikum AKH Wien

Discover of our interview series with Prof. med. Sabine Steiner, Principal Investigator of the study.

Prof. Steiner shares the motivation behind this essential research: exploring CO₂ Angiography as the contrast-free option of the future and protecting patients at high risk.

She highlights the urgent challenge of treating frail, older patients with restricted kidney function (GFR 30-60 ml/min) and explains why balancing complex interventions with renal protection is now an absolute priority.

🔹 The CO₂ Advantage, Confirmed:
The interview confirms CO₂ Angiography is a valid and promising alternative. While requiring some initial technical skill, participating centres have been “surprised by the great image quality” achieved in many patients. This potential positions CO₂ to “become routine” and define the new standard of care.

➡️ Watch the video to hear Prof. Steiner discuss the clinical vision and expectations behind the trial.

20/10/2025

From Vision. To Voice.

From crafting the perfect story to ensuring our message lands clearly across every channel, they keep the narrative flowing — strategically, consistently, every single day.

This is a glimpse into the world of our & team.
The ones who shape our perception and broadcast our mission globally 🌍📢